Intubating conditions and injection pain cisatracurium or rocuronium versus rocuronium cisatracurium combination
Middle East Journal of Anesthesiology. 2006; 18 (5): 879-886
em Inglês
| IMEMR
| ID: emr-79631
ABSTRACT
The present report evaluates the incidence of pain on intravenous injection and the condition oftracheal intubation at one minute following the administration of cisatracurium or rocuronium versus rocuronium-cisatracurium combination. We studied 60 patients, ASA 1, aged 18-60 years, undergoing elective surgical procedures. The patients were randomly assigned to 3 groups who received intravenously either 0.15 mg/kg cisatracurium [2ED[95]], 0,6 mg rocuronium [2ED[95]] or a combination of 0.075 mg/kg cisatracurium [ED[95]], plus 0.3 mg rocuronium [1ED[95]]. In the awake patients, the pain on injection of muscle relaxant was assessed on a four point scale [none, mild, moderate, severe]. Administration of the relaxant was followed by 1-2 mg/kg of lidocaine and 2 mg/kg propofol. Oro-tracheal intubation was performed 60 seconds following the administration of the relaxant. The intubating conditions were assessed and rated as excellent, good, fair or poor. The administration of 2ED[95] cisatracurium resulted in poor intubating conditions at 60s, without pain on injection. In contrast, the administration of 2ED[95] rocuronium resulted in excellent or good intubating conditions at 60s associated with high incidence of pain on injection in most of the patients. However, the combination of 1ED[95] cisatracurium with 1ED[95] rocuronium provided similar intubating conditions to the 2ED[95] rocuronium alone, associated with a significantly less pain on injection
Buscar no Google
Índice:
IMEMR (Mediterrâneo Oriental)
Assunto principal:
Dor
/
Atracúrio
/
Fármacos Neuromusculares não Despolarizantes
/
Intubação Intratraqueal
/
Bloqueadores Neuromusculares
Limite:
Feminino
/
Humanos
/
Masculino
Idioma:
Inglês
Revista:
Middle East J. Anesthesiol.
Ano de publicação:
2006
Similares
MEDLINE
...
LILACS
LIS